Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.
The following list is consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia may not participate in every one however the list is updated regularly.
If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email email@example.com or phone (03) 9662 9420.
Please click the heading in the left hand column to access consultation information from the relevant website.
Due 31 August 2018
|The MRFF Advisory Board is responsible for setting the spending priorities for the MRFF every two years. Consultation on the next MRFF Priorities has now commenced and included a series of public forums (now completed) and the opportunity to make written submissions.
A consultation paper is available and submissions can be made online.
Research Australia is preparing a response. To contribute to our submission, contact Greg Mullins, Head of Policy (see contact details above).
Due 21 September 2018
|Treasury is seeking submissions on the draft regulations for the proposed external conduct standards that charities registered with the Australian Charities and Not-for-profits Commission (ACNC) will need to comply with when operating outside Australia.
These relate to activities conducted outside Australia by the Charity and activities undertaken in collaboration with overseas third parties. It has the potential to catch any research expenditure overseas with international collaborators.
The proposed draft regulations will require overseas expenditure to be accounted for and reported separately, and impose an obligation on the Australian Charity to guard against corruption, manage conflicts of interest and ensure the safety of vulnerable individuals. This could be particularly relevant to clinical trials and other research conducted overseas with foreign research subjects, especially children.